T2S Group

image-broken

Opportunity

In December 2021, Helios acquired a majority stake in the largest and most diversified group of MedTech companies in Morocco. The consolidated group operates in medical devices, in vitro diagnostics and pharmaceuticals, and comprises four companies: Techniques Science Santé (“T2S”), IM Alliance, Cyclopharma and Binarios.

image-broken

Investment Summary

Date of investment

December 2021

Strategies

Private Equity

Share

Share on LinkedInShare on twitterShare by email
T2S Group | Helios Investment Partners